Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Aaron

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
JAMA|December 8, 2022
The FDA Struggle to Withdraw Makena: Problems With the Accelerated Approval ProcessDaniel G Aaron, I Glenn Cohen, Eli Y Adashi
JAMA|September 25, 2024
Legal Accountability for Health Crises: "Unshielding" the Sackler FamilyDaniel G Aaron, Adam J Levitin, Michael S Sinha
JAMA|August 28, 2023
Including E-Cigarettes in the FDA Rule Limiting NicotineDaniel G Aaron, Connor R Wallace, Michael S Sinha
American Journal of Public Health|June 11, 2025
Law and Policy Efforts to Dismantle Diversity, Equity, and InclusionDaniel G Aaron, Fatima C Stanford, Avery E Emery
JAMA|April 26, 2023
Court Intrusion Into Science and Medicine-The Mifepristone DecisionsDaniel G Aaron, Teneille R Brown, Michael S Sinha
JAMA|December 22, 2025
The FDA's Leucovorin Approval-A Departure From Evidentiary StandardsDaniel G Aaron, Michael S Sinha, I Glenn Cohen
JAMA|October 19, 2023
The Supreme Court's 303 Creative Decision and the Threat to LGBTQ+ Health CareElizabeth W Sepper, Joshua B Romero, Daniel G Aaron
JAMA Pediatrics|March 30, 2026
"Conversion Therapy" in the US-Progress, Missed Opportunities, and Future DirectionsKyle A Gavulic, John E Pachankis, Daniel G Aaron
JAMA Health Forum|October 11, 2024
The US FDA's New Rule for Regulating Laboratory-Developed TestsDaniel G Aaron, Eli Y Adashi, I Glenn Cohen
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2023
Supreme Court cases on affirmative action threaten diversity in medicineDaniel G Aaron, Simar S Bajaj, Fatima Cody Stanford
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
JAMA|December 8, 2022
The FDA Struggle to Withdraw Makena: Problems With the Accelerated Approval ProcessDaniel G Aaron, I Glenn Cohen, Eli Y Adashi
JAMA|September 25, 2024
Legal Accountability for Health Crises: "Unshielding" the Sackler FamilyDaniel G Aaron, Adam J Levitin, Michael S Sinha
JAMA|August 28, 2023
Including E-Cigarettes in the FDA Rule Limiting NicotineDaniel G Aaron, Connor R Wallace, Michael S Sinha
American Journal of Public Health|June 11, 2025
Law and Policy Efforts to Dismantle Diversity, Equity, and InclusionDaniel G Aaron, Fatima C Stanford, Avery E Emery
JAMA|April 26, 2023
Court Intrusion Into Science and Medicine-The Mifepristone DecisionsDaniel G Aaron, Teneille R Brown, Michael S Sinha
JAMA|December 22, 2025
The FDA's Leucovorin Approval-A Departure From Evidentiary StandardsDaniel G Aaron, Michael S Sinha, I Glenn Cohen
JAMA|October 19, 2023
The Supreme Court's 303 Creative Decision and the Threat to LGBTQ+ Health CareElizabeth W Sepper, Joshua B Romero, Daniel G Aaron
JAMA Pediatrics|March 30, 2026
"Conversion Therapy" in the US-Progress, Missed Opportunities, and Future DirectionsKyle A Gavulic, John E Pachankis, Daniel G Aaron
JAMA Health Forum|October 11, 2024
The US FDA's New Rule for Regulating Laboratory-Developed TestsDaniel G Aaron, Eli Y Adashi, I Glenn Cohen
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2023
Supreme Court cases on affirmative action threaten diversity in medicineDaniel G Aaron, Simar S Bajaj, Fatima Cody Stanford
Pageof 4